Innovative Vitality proudly offers the Galleri test by Grail. This test can identify a signal that is shared by over 50 types of cancer. It can also predict the cancer signal origin with incredible accuracy to help guide next steps. With one simple blood test, you can unlock answers that offer peace of mind, or the power of knowledge.
One simple blood draw is all it takes to get answers. The Galleri test blood draw takes just minutes to collect in our office. Results are available within a few days and will be released to your medical provider so they can review them with you.
Through a blood sample, Galleri looks for a signal associated with active cancer. Every time you take the test, Galleri checks more than 100,000 DNA regions and over a million specific DNA sites to screen for a signal shared by 50+ cancers at the time of your blood draw. If a cancer signal is detected, results from the test can predict the tissue type or organ associated with the cancer signal. More information can be found on the Galleri website.
The Galleri test is not covered by medical insurance at this time. The out of pocket cost for the Galleri test is $999.
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test is intended to be used in addition to, and not replace, other cancer screening tests your healthcare provider recommends. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
No. The Grail test is not an alternative to other screenings. It should be done in addition to cancer screenings recommended based on age or family history, such as mammograms, colonoscopies, etc.
A “Cancer Signal Detected” result is expected in approximately 1% or 1 out of 100 Galleri tests in people over 50 years of age. In a recent clinical study, on average, 4 out of 10 people with a “Cancer Signal Detected” result received a cancer diagnosis with diagnostic testing, and 1 out of 200 people without cancer received a “Cancer Signal Detected” result.
(Positive Predictive Value was 43% and False Positive rate was 0.5%)